ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2015

Safety and tolerability of exenatide once weekly in patients with type 2 diabetes: an integrated analysis of 4,328 patients.

Leigh MacConell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.